Delphia (USA)’s Allogene Therapeutics ALLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-13,714
| Closed | -$68.2K | – | 11 |
|
|
2023
Q2 | $68.2K | Sell |
13,714
-13,153
| -49% | -$65.4K | 0.11% | 205 |
|
|
2023
Q1 | $133K | Sell |
26,867
-4,472
| -14% | -$22.1K | 0.16% | 220 |
|
|
2022
Q4 | $197K | Buy |
31,339
+8,202
| +35% | +$51.6K | 0.23% | 207 |
|
|
2022
Q3 | $250K | Sell |
23,137
-14,576
| -39% | -$157K | 0.29% | 154 |
|
|
2022
Q2 | $430K | Buy |
37,713
+22,264
| +144% | +$254K | 0.3% | 108 |
|
|
2022
Q1 | $141K | Buy |
15,449
+5,226
| +51% | +$47.7K | 0.11% | 303 |
|
|
2021
Q4 | $153K | Buy |
+10,223
| New | +$153K | 0.16% | 233 |
|